恒指跌幅扩至440点 小米及药明生物挫4%-5%
恒指今早低开204点,跌幅扩至440点或1.8%,报23,302,回补6月1日部分上升裂口(23,089-23,539),成交额480亿元。
蓝筹股无一幸免,跌幅普遍逾1%-2%,受困於中美政治不确定性影响的汇控(00005.HK)继昨天曾跌破世纪供股价28元,低见27.5元喘定回稳後,今天又低见28元,现造28.05元,挫2.4%;中银(02388.HK)挫2.4%报20.45元创半年低。
恒生(00011.HK)及国寿(02628.HK)挫3.1%及3.5%,分别报110.5元(2012年以来新低)及17.14元(逾两个月低)。
科技股以小米(01810.HK)及瑞声(02018.HK)沽压最大,报19.96元及42.2元,挫4.3%及3.1%;腾讯(00700.HK)及阿里(09988.HK)分别低见506元及262元,最新跌幅轻微收窄至1.4%及1.8%。此外,药明生物(02269.HK)挫5%报181.9元,股价失守10天及20天线。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.